Sentara Parenteral Amino Acid Infusion Recalled for Sterility Concerns
Sentara Enterprises is recalling Parenteral Amino Acid Infusion 10% bags because product sterility cannot be guaranteed. The recall affects specific lots compounded in September 2015.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls are typically scored as Severe (4), especially for sterile medical products where sterility assurance is compromised, even without reported hospitalizations in the text.
Plain-English summary
Sentara Enterprises is recalling Parenteral Amino Acid Infusion 10% packaged in various Homepump sizes. The recall is due to a lack of assurance of sterility, meaning the product sterility cannot be guaranteed. The affected product is prescription-only and was distributed in Virginia and North Carolina.
The recall covers all lots compounded between September 11, 2015, and September 17, 2015. Specific quantities and expiration dates vary by bag size, ranging from 780ml to 3500ml. The source text does not report any specific illnesses or injuries associated with this recall.
Patients and healthcare providers should stop using the affected product and contact their healthcare provider for instructions on replacement or further care. Consumers should verify lot numbers and expiration dates against the recall details provided by the manufacturer.
The recalled product
- Product
- Parenteral Amino Acid Infusion 10%, Packaged in a) 780ML Homepumps, b) 1000ML Homepumps, c) 1140ML Homepumps, d) 1152ML Homepumps, e) 1400ML Homepumps, f) 1440ML Homepumps, g) 1500ML Homepumps, h) 1700ML Homepumps, i) 1900ML Homepumps, j) 2130ML Homepumps, k) 2250ML Homepumps…
- Manufacturer
- Sentara Enterprises
- Category
- Drug — Parenteral Nutrition
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 26-Sep-15
- b) 16-Sep-15 c) 25-Sep-15
- d) 25-Sep-15 e) 20-Sep-15
- 26-Sep-15
- f) 20-Sep-15
- 24-Sep-15
- g) 20-Sep-15
- h) 20-Sep-15
- i) 15-Sep-15
- j) 26-Sep-15
- k) 25-Sep-15
- l) 20-Sep-15
- 23-Sep-15
- m) 20-Sept-15
- n) 23-Sep-15
- o) 20-Sep-15
- p) 26-Sep-15
- q) 20-Sep-15
Distribution
Part of a larger recall action
This product is one of 34 recalled by Sentara Enterprises under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 34 products in this recall →Related recalls
Same manufacturer · Sentara Enterprises
See all →- SevereSentara Recalls Nafcillin Bags Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-02-03
- HighSentara Recalls Sodium Chloride Homepumps Due to Sterility Concerns
FDA (Drugs) · 2016-02-03
- SevereSentara Recalls Tobramycin Homepumps Due to Sterility Concerns
FDA (Drugs) · 2016-02-03
- SevereSentara Recalls Intralipid Fat Emulsion Due to Sterility Assurance Issues
FDA (Drugs) · 2016-02-03
- SevereSentara Recalls Gentamicin Homepumps Due to Sterility Concerns
FDA (Drugs) · 2016-02-03
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighSentara TPN Products Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighFDA Recalls TPN Nutrition Bags Due to Sterility Assurance Failure
FDA (Drugs) · 2023-02-22
- HighMeropenem Injectable Antibiotic Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighVancomycin Injectable Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighDextrose 10% TPN Solution Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2023-02-22
- HighFDA Class II: TPN solution bags lack sterility assurance
FDA (Drugs) · 2023-02-22